{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:53Z","timestamp":1787020193238,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PB-PG-0110-21073"],"award-info":[{"award-number":["PB-PG-0110-21073"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12882-015-0170-x","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T10:08:33Z","timestamp":1445854113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Karin","family":"Friedli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Almond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Chilcot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria da Silva","family":"Gane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Guirguis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Fineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wellsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Farrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"issue":"129 Suppl 1","key":"170_CR1","first-page":"31","volume":"2015","author":"Rao A, Casula A, Castledine C: UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in","year":"2013","unstructured":"Rao A, Casula A, Castledine C: UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in. National and Centre-specific Analyses. Nephron. 2013;2015(129 Suppl 1):31\u201356.","journal-title":"Nephron"},{"issue":"7178","key":"170_CR2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/bmj.318.7178.217","volume":"318","author":"SM Chandna","year":"1999","unstructured":"Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ. 1999;318(7178):217\u201323.","journal-title":"BMJ"},{"issue":"8","key":"170_CR3","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2005020157","volume":"16","author":"SD Weisbord","year":"2005","unstructured":"Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16(8):2487\u201394.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"170_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1525-139X.2009.00628.x","volume":"23","author":"J Chilcot","year":"2010","unstructured":"Chilcot J, Wellsted D, Farrington K. Depression in end-stage renal disease: current advances and research. Semin Dial. 2010;23(1):74\u201382.","journal-title":"Semin Dial"},{"issue":"3","key":"170_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.0894-0959.2004.17313.x","volume":"17","author":"PL Wang","year":"2004","unstructured":"Wang PL, Watnick SG. Depression: a common but underrecognized condition associated with end-stage renal disease. Semin Dial. 2004;17(3):237\u201341.","journal-title":"Semin Dial"},{"issue":"5","key":"170_CR6","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/ndt\/gfq611","volume":"26","author":"J Chilcot","year":"2011","unstructured":"Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K. An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant. 2011;26(5):1628\u201334.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"170_CR7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.genhosppsych.2006.03.008","volume":"28","author":"RA Drayer","year":"2006","unstructured":"Drayer RA, Piraino B, Reynolds 3rd CF, Houck PR, Mazumdar S, Bernardini J, et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry. 2006;28(4):306\u201312.","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"170_CR8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ki.2009.51","volume":"75","author":"D Cukor","year":"2009","unstructured":"Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223\u20139.","journal-title":"Kidney Int"},{"issue":"9","key":"170_CR9","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2215\/CJN.00220114","volume":"9","author":"SD Weisbord","year":"2014","unstructured":"Weisbord SD, Mor MK, Sevick MA, Shields AM, Rollman BL, Palevsky PM, et al. Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis. Clin J Am Soc Nephrol. 2014;9(9):1594\u2013602.","journal-title":"Clin J Am Soc Nephrol"},{"key":"170_CR10","doi-asserted-by":"crossref","unstructured":"Rabindranath K, Butler J, Macleod A, Roderick P, Wallace S, Daly C. Physical measures for treating depression in dialysis patients. Cochrane Database Syst Rev. 2005;2.","DOI":"10.1002\/14651858.CD004541.pub2"},{"issue":"1","key":"170_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2190\/WQ33-M54T-XN7L-V8MX","volume":"27","author":"M Blumenfield","year":"1997","unstructured":"Blumenfield M, Levy NB, Spinowitz B, Charytan C, Beasley Jr CM, Dubey AK, et al. Fluoxetine in depressed patients on dialysis. Int J Psychiatry Med. 1997;27(1):71\u201380.","journal-title":"Int J Psychiatry Med"},{"issue":"5","key":"170_CR12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0272-6386(05)80018-6","volume":"37","author":"D Wuerth","year":"2001","unstructured":"Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis. 2001;37(5):1011\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"170_CR13","first-page":"60","volume":"50","author":"SH Kennedy","year":"1989","unstructured":"Kennedy SH, Craven JL, Rodin GM. Major depression in renal dialysis patients: an open trial of antidepressant therapy. J Clin Psychiatry. 1989;50(2):60\u20133.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"170_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200501000-00001","volume":"329","author":"JR Koo","year":"2005","unstructured":"Koo JR, Yoon JY, Joo MH, Lee HS, Oh JE, Kim SG, et al. Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients. Am J Med Sci. 2005;329(1):1.","journal-title":"Am J Med Sci"},{"issue":"2","key":"170_CR15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11255-009-9686-y","volume":"42","author":"H Atalay","year":"2010","unstructured":"Atalay H, Solak Y, Biyik M, Biyik Z, Yeksan M, Uguz F, et al. Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients. Int Urol Nephrol. 2010;42(2):527\u201336.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"170_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0163-8343(95)00073-9","volume":"18","author":"NB Levy","year":"1996","unstructured":"Levy NB, Blumenfield M, Beasley Jr CM, Dubey AK, Solomon RJ, Todd R, et al. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. Gen Hosp Psychiatry. 1996;18(1):8\u201313.","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"170_CR17","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1093\/ndt\/gfs295","volume":"27","author":"EV Nagler","year":"2012","unstructured":"Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3\u20135 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736\u201345.","journal-title":"Nephrol Dial Transplant"},{"issue":"9665","key":"170_CR18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746\u201358.","journal-title":"Lancet"},{"issue":"6","key":"170_CR19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","volume":"288","author":"AH Glassman","year":"2002","unstructured":"Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger Jr JT, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701\u20139.","journal-title":"JAMA"},{"issue":"3","key":"170_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199324030-00003","volume":"24","author":"J Harten van","year":"1993","unstructured":"van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet. 1993;24(3):203\u201320.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"170_CR21","first-page":"121","volume":"44","author":"MH Schwenk","year":"1995","unstructured":"Schwenk MH, Verga MA, Wagner JD. Hemodialyzability of sertraline. Clin Nephrol. 1995;44(2):121\u20134.","journal-title":"Clin Nephrol"},{"issue":"1","key":"170_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53\u201372.","journal-title":"Health Policy"},{"key":"170_CR23","volume-title":"Manual for the BDI-II","author":"A Beck","year":"1996","unstructured":"Beck A, Steer R, Brown G. Manual for the BDI-II. San Antonio, TX: Psychological Corporation; 1996."},{"issue":"Suppl 20","key":"170_CR24","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22\u201333. quiz 34\u201357.","journal-title":"J Clin Psychiatry"},{"key":"170_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"9","key":"170_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3928\/0048-5713-20020901-06","volume":"32","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: A new depression diagnostic and severity measure. Psychiat Ann. 2002;32(9):509\u201315.","journal-title":"Psychiat Ann"},{"issue":"3","key":"170_CR27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State - Practical Method for Grading Cognitive State of Patients for Clinician. J Psychiat Res. 1975;12(3):189\u201398.","journal-title":"J Psychiat Res"},{"issue":"7","key":"170_CR28","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry. 2007;4(7):28\u201337.","journal-title":"Psychiatry"},{"issue":"5","key":"170_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"170_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00451725","volume":"3","author":"RD Hays","year":"1994","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329\u201338.","journal-title":"Qual Life Res"},{"issue":"3","key":"170_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G EuroQol","year":"1990","unstructured":"EuroQol G. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"key":"170_CR32","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.","journal-title":"BMJ"},{"key":"170_CR33","doi-asserted-by":"crossref","unstructured":"Dube P, Kurt K, Bair MJ, Theobald D, Williams LS. (2010). The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Prim Care Companion J Clin Psychiatry, 12(6).","DOI":"10.4088\/PCC.10m00978blu"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0170-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:13:00Z","timestamp":1498241580000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2369\/16\/172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1186\/s12882-015-0170-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]},"article-number":"172"}}